Similar companies
| Company | Revenue | |
|---|---|---|
 |
Veeva SystemsVEEV |
721M 3.1% |
Income Statement (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Revenue | 312M | 3.8% |
| Gross Profit | 189M | 4.1% |
| Cost of Revenue | 123M | 18.7% |
| Operating expense | 147M | 17.2% |
| Net Income | 26M | 362.3% |
| EBITDA | 84M | 29.7% |
Balance Sheet (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Total Assets | 3.45B | 1.1% |
| Total Liabilities | 1.33B | 2.2% |
| Total Equity | 2.11B | 0.5% |
| Shares Outstanding | 89M | 0.6% |
Cash Flow (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Cash from operations | 76M | 16.3% |
| Cash from financing | -88M | 7.3% |
EPS
Financial Highlights for Healthequity in Q1 '25
Healthequity reported a revenue of 312M, which is a 3.8% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 189M, marking a -4.1% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 123M, a 18.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 147M, showing a -17.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 26M, showing a 362.3% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 84M, showing a 29.7% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Healthequity faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
